rts logo

Insmed Inc (INSM) Stock Could Soon Reward Patient Investors

Insmed Inc (NASDAQ: INSM) is -15.13% lower on its value in year-to-date trading and has touched a low of $16.25 and a high of $32.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The INSM stock was last observed hovering at around $26.72 in the last trading session, with the day’s loss setting it -0.42%.

Currently trading at $26.30, the stock is -2.73% and -5.19% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.02 million and changing -1.57% at the moment leaves the stock 4.15% off its SMA200. INSM registered 56.92% gain for a year compared to 6-month gain of 4.16%. The firm has a 50-day simple moving average (SMA 50) of $14.19 and a 200-day simple moving average (SMA200) of -$6.56.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The stock witnessed a -6.27% loss in the last 1 month and extending the period to 3 months gives it a -15.13%, and is -2.59% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.42% over the week and 3.11% over the month.

Insmed Inc (INSM) has around 912 employees, a market worth around $3.91B and $305.21M in sales. Profit margin for the company is -245.59%. Distance from 52-week low is 61.80% and -17.81% from its 52-week high. The company has generated returns on investments over the last 12 months (-73.74%).

Insmed Inc quarterly earnings per share for the current quarter are estimated at -$1.23 with sales reaching $78.58M over the same period.The EPS is expected to grow by 12.58% this year, but quarterly earnings will post 16.60% year-over-year. Quarterly sales are estimated to grow 21.80% in year-over-year returns.

Insmed Inc (INSM) Top Institutional Holders

374 institutions hold shares in Insmed Inc (INSM), with institutional investors hold 104.55% of the company’s shares. The shares outstanding are 147.98M, and float is at 144.65M with Short Float at 6.11%. Institutions hold 103.28% of the Float.

The top institutional shareholder in the company is Vanguard Group Inc with over 13.32 million shares valued at $281.06 million. The investor’s holdings represent 9.26% of the INSM Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 10.26 million shares valued at $216.45 million to account for 7.13% of the shares outstanding. The other top investors are Price (T.Rowe) Associates Inc which holds 10.17 million shares representing 7.07% and valued at over $214.64 million, while T. Rowe Price Investment Management, Inc. holds 5.77% of the shares totaling 8.3 million with a market value of $175.22 million.

Insmed Inc (INSM) Insider Activity

The most recent transaction is an insider sale by Adsett Roger,the company’sChief Operating Officer. SEC filings show that Adsett Roger sold 5,251 shares of the company’s common stock on Jan 12 ’24 at a price of $28.63 per share for a total of $0.15 million. Following the sale, the insider now owns 0.15 million shares.

Insmed Inc disclosed in a document filed with the SEC on Jan 12 ’24 that Flammer Martina M.D. (Chief Medical Officer) sold a total of 4,667 shares of the company’s common stock. The trade occurred on Jan 12 ’24 and was made at $28.63 per share for $0.13 million. Following the transaction, the insider now directly holds 0.11 million shares of the INSM stock.

Still, SEC filings show that on Jan 10 ’24, Adsett Roger (Chief Operating Officer) disposed off 3,536 shares at an average price of $28.90 for $0.1 million. The insider now directly holds 153,810 shares of Insmed Inc (INSM).

Related Posts